• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间歇性给予甲状旁腺激素(PTH)对大鼠骨骼中sost信使核糖核酸(mRNA)和蛋白质的影响。

Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.

作者信息

Silvestrini G, Ballanti P, Leopizzi M, Sebastiani M, Berni S, Di Vito M, Bonucci E

机构信息

Dipartimento di Medicina Sperimentale e Patologia, Sezioni di Anatomia Patologica, Università degli Studi di Roma La Sapienza, Azienda Policlinico Umberto I, Viale Regina Elena, 324, 00161 Rome, Italy.

出版信息

J Mol Histol. 2007 Aug;38(4):261-9. doi: 10.1007/s10735-007-9096-3. Epub 2007 Jun 5.

DOI:10.1007/s10735-007-9096-3
PMID:17549589
Abstract

Sclerostin, the secreted protein product of the SOST gene, which is mainly expressed by osteocytes, has recently been proposed as a negative regulator of bone osteoblastogenesis. Chronic elevation of PTH reduces SOST expression by osteocytes, while controversial results have been obtained by intermittent PTH administration. We have investigated the effects of intermittently administered PTH on SOST expression and sclerostin localization, comparing them with those of controls, as they appeared in three different bone segments of rat tibia: secondary trabecular metaphyseal and epiphyseal bone, and cortical diaphyseal bone. The histomorphometric results demonstrate that PTH enhances bone turnover through anabolic effects, as shown by the association of increased bone resorption variables with a significant rise in BV/TV, Tb.Th and Tb.N and a fall in Tb.Sp. PTH induces a SOST mRNA and protein fall in secondary metaphyseal trabeculae, diaphyseal bone and in epiphyseal trabeculae. Numbers of sclerostin immunopositive osteocytes/mm(2) show no change, compared with controls; there are fewer sclerostin-positive osteocytes in secondary metaphyseal trabeculae than in the other two bone areas, both in the control and PTH groups. The low numbers of sclerostin-positive osteocytes in the metaphyseal trabecular bone seem to be directly related to the fact that this area displays a high remodeling rate. The anabolic effects of PTH are in line with the fall of SOST mRNA and protein in all the three bone segments examined; the rise of bone turnover supports a negative role of SOST in bone formation.

摘要

硬化素是SOST基因的分泌蛋白产物,主要由骨细胞表达,最近被认为是骨成骨细胞生成的负调节因子。甲状旁腺激素(PTH)的持续升高会降低骨细胞中SOST的表达,而间歇性给予PTH的结果则存在争议。我们研究了间歇性给予PTH对SOST表达和硬化素定位的影响,并将其与对照组进行比较,观察它们在大鼠胫骨的三个不同骨段中的表现:次级小梁干骺端和骨骺骨,以及皮质骨干骨。组织形态计量学结果表明,PTH通过合成代谢作用增强骨转换,这表现为骨吸收变量增加与骨体积/组织体积(BV/TV)、骨小梁厚度(Tb.Th)和骨小梁数量(Tb.N)显著增加以及骨小梁间距(Tb.Sp)降低相关。PTH诱导次级干骺端小梁、骨干骨和骨骺小梁中SOST mRNA和蛋白水平下降。与对照组相比,硬化素免疫阳性骨细胞数量/平方毫米无变化;在对照组和PTH组中,次级干骺端小梁中的硬化素阳性骨细胞均少于其他两个骨区域。干骺端小梁骨中硬化素阳性骨细胞数量较少似乎与该区域具有高重塑率这一事实直接相关。PTH的合成代谢作用与所有三个检测骨段中SOST mRNA和蛋白的下降一致;骨转换的增加支持了SOST在骨形成中的负作用。

相似文献

1
Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.间歇性给予甲状旁腺激素(PTH)对大鼠骨骼中sost信使核糖核酸(mRNA)和蛋白质的影响。
J Mol Histol. 2007 Aug;38(4):261-9. doi: 10.1007/s10735-007-9096-3. Epub 2007 Jun 5.
2
OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST.甲状旁腺激素治疗大鼠的初级和次级干骺端小梁骨中OPG和RANKL的mRNA及蛋白表达与sost的表达无关。
J Mol Histol. 2008 Apr;39(2):237-42. doi: 10.1007/s10735-007-9158-6. Epub 2007 Dec 20.
3
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.小鼠甲状旁腺激素的慢性升高会降低骨细胞中硬化蛋白的表达:一种激素控制成骨细胞生成的新机制。
Endocrinology. 2005 Nov;146(11):4577-83. doi: 10.1210/en.2005-0239. Epub 2005 Aug 4.
4
Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.甲状旁腺激素诱导的Sost抑制需要脂蛋白受体相关蛋白6。
Ann N Y Acad Sci. 2016 Jan;1364(1):62-73. doi: 10.1111/nyas.12750. Epub 2015 Apr 2.
5
SOST is a target gene for PTH in bone.硬化蛋白是甲状旁腺激素在骨骼中的一个靶基因。
Bone. 2005 Aug;37(2):148-58. doi: 10.1016/j.bone.2005.03.018.
6
Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D.人类SOST基因对1α,25 - 二羟基维生素D刺激的早期反应。
J Steroid Biochem Mol Biol. 2016 Nov;164:369-373. doi: 10.1016/j.jsbmb.2015.12.006. Epub 2015 Dec 9.
7
Does osteocytic SOST suppression mediate PTH bone anabolism?成骨细胞 SOST 抑制是否介导了 PTH 的骨合成代谢作用?
Trends Endocrinol Metab. 2010 Apr;21(4):237-44. doi: 10.1016/j.tem.2009.12.002. Epub 2010 Jan 13.
8
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.降钙素削弱了 PTH 在幼鼠中的合成代谢作用,并刺激了骨细胞中硬化蛋白的表达。
Bone. 2010 Jun;46(6):1486-97. doi: 10.1016/j.bone.2010.02.018. Epub 2010 Feb 24.
9
Control of the SOST bone enhancer by PTH using MEF2 transcription factors.甲状旁腺激素通过MEF2转录因子对SOST骨增强子的调控。
J Bone Miner Res. 2007 Dec;22(12):1957-67. doi: 10.1359/jbmr.070804.
10
Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.单独使用雌激素或与甲状旁腺激素联合使用,可降低去卵巢大鼠的椎骨MEF2和硬化蛋白表达,并增加椎骨骨量。
Osteoporos Int. 2014 Dec;25(12):2743-54. doi: 10.1007/s00198-014-2818-y. Epub 2014 Jul 30.

引用本文的文献

1
Role of SOST in Response to Mechanical Stimulation in Bone and Extraosseous Organs.骨硬化蛋白(SOST)在骨骼和骨外器官对机械刺激的反应中的作用。
Biomolecules. 2025 Jun 11;15(6):856. doi: 10.3390/biom15060856.
2
Parathyroid hormone (1-34) retards the lumbar facet joint degeneration and activates Wnt/β-catenin signaling pathway in ovariectomized rats.甲状旁腺激素(1-34)可延缓腰椎小关节退变,并激活去卵巢大鼠的 Wnt/β-连环蛋白信号通路。
J Orthop Surg Res. 2024 Jun 14;19(1):352. doi: 10.1186/s13018-024-04817-6.
3
Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats.

本文引用的文献

1
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.成骨细胞中的Wnt信号通路调节核因子κB受体活化因子配体的表达,并在体外抑制破骨细胞生成。
J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96. doi: 10.1242/jcs.02883. Epub 2006 Mar 7.
2
Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.甲状旁腺激素通过Smad3增加小鼠成骨细胞中的β-连环蛋白水平。
Endocrinology. 2006 May;147(5):2583-90. doi: 10.1210/en.2005-1627. Epub 2006 Feb 16.
3
Sclerostin and Wnt signaling--the pathway to bone strength.
艾地骨化醇诱导基于微结构模型的骨形成,并优先抑制大鼠长骨骺端而非干骺端的硬化蛋白合成。
Int J Mol Sci. 2024 Apr 11;25(8):4257. doi: 10.3390/ijms25084257.
4
Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.只有生物活性形式的 PTH(n-端氧化 PTH 和 Met18(氧化)-PTH)可抑制骨硬化蛋白的合成——来自体外和人体研究的证据。
Pflugers Arch. 2024 Jun;476(6):889-899. doi: 10.1007/s00424-024-02928-x. Epub 2024 Feb 23.
5
Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry.骨硬化蛋白是口腔炎症和再生牙科治疗的一个有前途的靶点。
J Transl Med. 2022 May 13;20(1):221. doi: 10.1186/s12967-022-03417-4.
6
Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model.在原发性甲状旁腺功能亢进模型中,甲状旁腺激素调节骨硬化蛋白和FGF23的循环水平。
J Endocr Soc. 2022 Feb 18;6(4):bvac027. doi: 10.1210/jendso/bvac027. eCollection 2022 Apr 1.
7
Antitumor Effect of Sclerostin against Osteosarcoma.硬化蛋白对骨肉瘤的抗肿瘤作用
Cancers (Basel). 2021 Nov 29;13(23):6015. doi: 10.3390/cancers13236015.
8
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study.单次唑来膦酸给药后血清全段甲状旁腺素和硬化蛋白水平变化的关系:一项 1 期药代动力学研究的结果。
Calcif Tissue Int. 2022 Jan;110(1):87-92. doi: 10.1007/s00223-021-00900-w. Epub 2021 Aug 24.
9
Role of Gut Microbiota in the Skeletal Response to PTH.肠道微生物群在甲状旁腺激素对骨骼反应中的作用。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):636-645. doi: 10.1210/clinem/dgaa895.
10
Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota.甲状旁腺激素依赖性骨形成需要肠道微生物群产生丁酸。
J Clin Invest. 2020 Apr 1;130(4):1767-1781. doi: 10.1172/JCI133473.
硬化蛋白与Wnt信号通路——通往骨强度之路
J Clin Endocrinol Metab. 2005 Dec;90(12):6741-3. doi: 10.1210/jc.2005-2370.
4
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.骨质疏松症的发病机制:概念、争议与展望。
J Clin Invest. 2005 Dec;115(12):3318-25. doi: 10.1172/JCI27071.
5
Bone mineral density in sclerosteosis; affected individuals and gene carriers.骨硬化症患者及基因携带者的骨矿物质密度
J Clin Endocrinol Metab. 2005 Dec;90(12):6392-5. doi: 10.1210/jc.2005-1235. Epub 2005 Sep 27.
6
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.硬化蛋白是一种由骨细胞延迟分泌的产物,可抑制骨形成。
FASEB J. 2005 Nov;19(13):1842-4. doi: 10.1096/fj.05-4221fje. Epub 2005 Aug 25.
7
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.小鼠甲状旁腺激素的慢性升高会降低骨细胞中硬化蛋白的表达:一种激素控制成骨细胞生成的新机制。
Endocrinology. 2005 Nov;146(11):4577-83. doi: 10.1210/en.2005-0239. Epub 2005 Aug 4.
8
SOST is a target gene for PTH in bone.硬化蛋白是甲状旁腺激素在骨骼中的一个靶基因。
Bone. 2005 Aug;37(2):148-58. doi: 10.1016/j.bone.2005.03.018.
9
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.sost/硬骨素,一种由骨细胞衍生的骨形成负调节因子。
Cytokine Growth Factor Rev. 2005 Jun;16(3):319-27. doi: 10.1016/j.cytogfr.2005.02.005.
10
Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.Wnt/β-连环蛋白——脊椎动物骨骼中细胞命运选择的经典故事。
Dev Cell. 2005 May;8(5):626-7. doi: 10.1016/j.devcel.2005.04.008.